Eclampsia and Posterior Reversible Encephalopathy Syndrome (PRES):

Stopped early · Not applicable · Has a placebo group

Conditions studied: Eclampsia

In brief

This is a double blinded, placebo-controlled trial to determine if IV dexamethasone more quickly than placebo assists resolution of Posterior Reversible Encephalopathy Syndrome (PRES) encountered in eclamptic patients. All patients regardless of assignment to placebo or steroid will receive standard therapy to include magnesium sulfate, blood pressure medications and diuretics. We hypothesize that the addition of dexamethasone to standard therapy will accelerate CNS recovery more quickly than standard management without dexamethasone.

Key facts

Study ID

NCT02027272

Run by

University of Mississippi Medical Center

People needed

1

Starts

2012-02-01

Expected to finish

2013-12-01

Last updated by the study team

2016-05-26

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Currently 34 weeks pregnant or within 6 weeks postpartum
• At least 18 years of age
• Singleton or twin gestation
• Patient or family sign informed consent
• Diagnosis of eclampsia
• Able to obtain MRI scanning within 24hours of hosp admit and/or seizure

You may not qualify if…

• Neither pregnant nor within first 6 weeks postpartum
• Patient or family unable to sign informed consent
• Less than 18 years of age
• Triplet or higher order gestation
• Unable to obtain MRI scanning within 24 hours of hospital admission (
• Diagnosis of cerebral hemorrhage
• Patient in whom MRI is contraindicated

Where it is running

• University of Mississippi Medical Center — Jackson, Mississippi, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.